US FDA issues warning about propylhexedrine

26 March 2021 - Deborah Wilkes

Premium

The US Food and Drug Administration (FDA) has asked manufacturers of the OTC nasal decongestant propylhexedrine to “consider product design changes that support its safe use”.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: